Jonathan Freve

Insider Reports History

Entity
Individual
Location
C/O Spring Bank Pharmaceuticals, Inc., 113 Cedar Street, Ste S 7, Milford, MA
Signature
/s/ Lori Firmani, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jonathan Freve:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Galecto, Inc. Chief Financial Officer Restricted Stock Units 100K $75K $0.75 Jan 3, 2024 Direct
Galecto, Inc. Chief Financial Officer Stock Option (right to buy) 115K Jan 4, 2023 Direct

Insider Reports Filed by Jonathan Freve

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GLTO Galecto, Inc. Jan 3, 2024 1 $0 4 Jan 5, 2024 Chief Financial Officer
GLTO Galecto, Inc. Jan 4, 2023 1 $0 4 Jan 5, 2023 Chief Financial Officer
GLTO Galecto, Inc. Jan 4, 2022 1 $0 4 Jan 6, 2022 Chief Financial Officer
GLTO Galecto, Inc. Dec 3, 2021 1 $9.96K 4 Dec 6, 2021 Chief Financial Officer
GLTO Galecto, Inc. Nov 8, 2021 1 $10.2K 4 Nov 9, 2021 Chief Financial Officer
GLTO Galecto, Inc. Aug 18, 2021 1 $11.8K 4 Aug 19, 2021 Chief Financial Officer
GLTO Galecto, Inc. Jun 23, 2021 1 $9.48K 4 Jun 23, 2021 Chief Financial Officer